SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $383 | -51.4% | 18,607 | +11.0% | 0.00% | -33.3% |
| Q2 2023 | $788 | +69.5% | 16,760 | +51.1% | 0.01% | +20.0% |
| Q1 2023 | $465 | -46.9% | 11,092 | -51.7% | 0.01% | -54.5% |
| Q4 2022 | $876 | -99.8% | 22,974 | +119.0% | 0.01% | +120.0% |
| Q3 2022 | $411,000 | -48.0% | 10,492 | -57.1% | 0.01% | -37.5% |
| Q2 2022 | $791,000 | -76.2% | 24,481 | -75.6% | 0.01% | -66.7% |
| Q1 2022 | $3,327,000 | +440.1% | 100,509 | +594.2% | 0.02% | +700.0% |
| Q4 2021 | $616,000 | -79.5% | 14,478 | -78.6% | 0.00% | -78.6% |
| Q3 2021 | $3,002,000 | +118.8% | 67,750 | +180.5% | 0.01% | +133.3% |
| Q2 2021 | $1,372,000 | -7.7% | 24,151 | +21.5% | 0.01% | -25.0% |
| Q1 2021 | $1,487,000 | -20.1% | 19,870 | -7.7% | 0.01% | -20.0% |
| Q4 2020 | $1,862,000 | +74.8% | 21,519 | +23.5% | 0.01% | +42.9% |
| Q3 2020 | $1,065,000 | +103.2% | 17,431 | +366.4% | 0.01% | +75.0% |
| Q3 2019 | $524,000 | +35.4% | 3,737 | +77.0% | 0.00% | +33.3% |
| Q2 2019 | $387,000 | +15.5% | 2,111 | +0.3% | 0.00% | 0.0% |
| Q1 2019 | $335,000 | +3.4% | 2,104 | -37.8% | 0.00% | 0.0% |
| Q4 2018 | $324,000 | -11.0% | 3,385 | +31.5% | 0.00% | 0.0% |
| Q3 2018 | $364,000 | +160.0% | 2,575 | +187.7% | 0.00% | +200.0% |
| Q2 2018 | $140,000 | -83.4% | 895 | -82.9% | 0.00% | -85.7% |
| Q1 2018 | $843,000 | +98.4% | 5,233 | -23.2% | 0.01% | +75.0% |
| Q3 2017 | $425,000 | +58.6% | 6,814 | +102.9% | 0.00% | +100.0% |
| Q2 2017 | $268,000 | +7.2% | 3,359 | -4.7% | 0.00% | 0.0% |
| Q1 2017 | $250,000 | -65.2% | 3,524 | -75.0% | 0.00% | -66.7% |
| Q4 2016 | $719,000 | +192.3% | 14,078 | +163.5% | 0.01% | +100.0% |
| Q3 2016 | $246,000 | +70.8% | 5,343 | +56.7% | 0.00% | +200.0% |
| Q3 2015 | $144,000 | -8.9% | 3,409 | -20.8% | 0.00% | 0.0% |
| Q4 2014 | $158,000 | – | 4,305 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |